Page 2 - Drug Market

Cipla posts net profit of Rs 665 cr in Q2, income from ops grows 15%

The company's prescription biz grew 14% YoY supported by continued traction in the Covid portfolio

Families struggle to import life-saving drugs as lockdown hits grey market

With no new stock coming in, both patients and grey market vendors started running out of vigabatrin

Investors look beyond drug makers as rush for Covid treatment hots up

A record 48 per cent of fund managers are overweight healthcare stocks, a Bank of America survey has shown

Domestic drug market stares at supply crisis due to coronavirus outbreak

Big pharma companies, however, said while it was true that formulation players would not rush to buy raw material, they could not afford losing customers.

Indian drug formulation market grows 15.3% in Aug

Indian companies grew by 17.1% against 9% growth for MNC pharma companies during the month